Disorders of ovarian function in childhood and adolescence: evolving needs of the growing child. An endocrine perspective.
Over the past 15 years there have been changes in the care of children and adolescents paralleling increased longevity of those with chronic illnesses and increased survival after childhood cancer and organ transplantation. A broad understanding of holistic management and long-term risks is required. Optimisation of pubertal progress and normalisation of bone and hormonal health by the end of puberty will reduce the impact of later adult bone loss in chronic disease conditions. Psychosocial issues related to both precocious and delayed puberty can have profound effects on family function.
Zacharin
M
M
Department of Endocrinology and Diabetes, The Royal Children's Hospital, Melbourne, Vic., Australia. margaret.zacharin@rch.org.au
D000293:Adolescent; D000328:Adult; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D005693:Galactosemias / Q000209:etiology; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007006:Hypogonadism / Q000503:physiopathology; D007027:Hypothalamic Diseases / Q000150:complications / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D010049:Ovarian Diseases / Q000150:complications* / Q000503:physiopathology; D011247:Pregnancy; D011627:Puberty / Q000187:drug effects / Q000502:physiology / Q000523:psychology; D011629:Puberty, Precocious / Q000503:physiopathology; D017741:Survivors; D014424:Turner Syndrome / Q000188:drug therapy / Q000503:physiopathology; D014599:Uterus / Q000254:growth & development; D055815:Young Adult